Tratamiento sistémico en la enfermedad oligometastásica - page 7

NCT02489318

ARN-509 in combination with ADT versus ADT

alone in chemotherapy-naive patients with low-

volume mHSPC

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6 8,9,10,11,12,13,14,15,16,17,...31